Peptide clinic marketing runs into a wall that most cash-pay medicine does not. A large share of what these clinics prescribe is compounded rather than commercially manufactured, and a meaningful part of it has never been through FDA approval. Ad platforms treat that as a restricted category. Google's healthcare and medicines policy limits who may advertise prescription drugs and effectively excludes unapproved ones, and Meta's rules land in the same place. The practical result is that the paid search playbook a medspa or a dental practice would use is not available to you, and the clinics that try to force it usually end up with a suspended account rather than a pipeline.
What works instead is the slower channel, and it happens to be the one with better economics. Patients researching peptides search by compound and by protocol — the specific names, the dosing questions, the safety questions, whether a thing is legal to prescribe at all. Those searches are long, specific, and almost entirely unclaimed by clinics, because most practices publish a single services page listing peptides as a bullet and nothing else. A page per compound that answers the real question, written to a standard a physician would sign off on, is how you become the result rather than the eleventh option on it.
The rest is trust and tracking. Peptide medicine sits close enough to the grey market that patients are actively looking for a reason not to believe you, so reviews, named clinicians and plain language about what is and is not approved do more conversion work here than in any adjacent category. Underneath that, every inquiry gets a tracked number so you can see which compound page and which query produced the consult. Without it a peptide clinic is guessing, and guessing is expensive when your only working channel takes months to compound.